Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-008074
Filing Date
2022-04-05
Accepted
2022-04-05 14:17:28
Documents
2
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3668
2 POWER OF ATTORNEY poa_narwold.htm EX-24.1 11546
  Complete submission text file 0001567619-22-008074.txt   16589
Mailing Address ALBEMARLE CORPORATION 451 FLORIDA STREET BATON ROUGE LA 707801
Business Address
NARWOLD KAREN G (Reporting) CIK: 0001095670 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37586 | Film No.: 22806162

Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Issuer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products